Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihisa Nukui

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Respirology Case Reports|June 23, 2022
Pleurisy with pneumothorax due to CAM-resistant MAC lung diseaseYoshihisa Nukui, Tatsuo Kawahara, Satoshi Hanzawa
Internal Medicine (Tokyo, Japan)|December 27, 2022
Mass-like Lesions Causing Compression of Large Vessels in Granulomatosis with PolyangiitisSatoshi Hanzawa, Seiji Noda, Tadashi Hosoya, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosisYoshihisa Nukui, Yasunari Miyazaki, Kozo Suhara, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 9, 2011
[A case of melioidosis occurring after a long-term stay in Vietnam that developed pulmonary cavitation and relapsed with multiple pulmonary nodules]Kiyoko Kurata, Yoshihisa Nukui, Hiroyuki Shimada, et al.
The Clinical Respiratory Journal|February 3, 2016
Interstitial changes in asthma-COPD overlap syndromeSahoko Chiba, Kimitake Tsuchiya, Yoshihisa Nukui, et al.
Immunity, Inflammation and Disease|October 5, 2020
Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitisYukihisa Inoue, Tsukasa Okamoto, Takayuki Honda, et al.
Respiratory Investigation|September 13, 2020
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung diseaseNaoki Nishiyama, Masahiro Masuo, Yoshihisa Nukui, et al.
Plos One|August 2, 2019
Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitisYoshihisa Nukui, Takashi Yamana, Masahiro Masuo, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 16, 2019
Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitisYoshihisa Nukui, Yasunari Miyazaki, Masahiro Masuo, et al.
Thoracic Cancer|March 24, 2022
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114)Hiroyuki Sakashita, Ken Uchibori, Yasuto Jin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Respirology Case Reports|June 23, 2022
Pleurisy with pneumothorax due to CAM-resistant MAC lung diseaseYoshihisa Nukui, Tatsuo Kawahara, Satoshi Hanzawa
Internal Medicine (Tokyo, Japan)|December 27, 2022
Mass-like Lesions Causing Compression of Large Vessels in Granulomatosis with PolyangiitisSatoshi Hanzawa, Seiji Noda, Tadashi Hosoya, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosisYoshihisa Nukui, Yasunari Miyazaki, Kozo Suhara, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 9, 2011
[A case of melioidosis occurring after a long-term stay in Vietnam that developed pulmonary cavitation and relapsed with multiple pulmonary nodules]Kiyoko Kurata, Yoshihisa Nukui, Hiroyuki Shimada, et al.
The Clinical Respiratory Journal|February 3, 2016
Interstitial changes in asthma-COPD overlap syndromeSahoko Chiba, Kimitake Tsuchiya, Yoshihisa Nukui, et al.
Immunity, Inflammation and Disease|October 5, 2020
Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitisYukihisa Inoue, Tsukasa Okamoto, Takayuki Honda, et al.
Respiratory Investigation|September 13, 2020
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung diseaseNaoki Nishiyama, Masahiro Masuo, Yoshihisa Nukui, et al.
Plos One|August 2, 2019
Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitisYoshihisa Nukui, Takashi Yamana, Masahiro Masuo, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 16, 2019
Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitisYoshihisa Nukui, Yasunari Miyazaki, Masahiro Masuo, et al.
Thoracic Cancer|March 24, 2022
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114)Hiroyuki Sakashita, Ken Uchibori, Yasuto Jin, et al.
Pageof 2